
Machine learning to identify and prioritise drug targets
Science, Technology and innovation Open Targets is using artificial intelligence and machine learning to identify and prioritise drug targets.
2023
sciencetechnology-and-innovation
Science, Technology and innovation Open Targets is using artificial intelligence and machine learning to identify and prioritise drug targets.
2023
sciencetechnology-and-innovation
Announcements, Science Open data resources that enable global research and development recognised by the Global Biodata Coalition.
2022
announcementsscience
Perspectives, Science Our experts discuss the importance of open science for food security and preserving global biodiversity.
2022
perspectivesscience
Lab Matters Newly appointed member of the ASAPbio Board of Directors, EMBL Group Leader Gautam Dey speaks about preprints, data management, and open science.
2022
lab-matters
Perspectives, Science Ewan Birney, Deputy Director General of EMBL and Director of EMBL-EBI, reveals the key factors that enabled AlphaFold to change the world of biology.
2022
perspectivesscience
Research highlights, Science A new method for the robust analysis of copy number variation and used UK Biobank data to identify links between genome and disease.
2022
research-highlightsscience
Lab Matters EMBL’s new archive and records manager, Maria Papanikolaou, explains the dual role she and an additional colleague will have in the Office of Science Information Management.
2022
lab-matters
Lab Matters Fergal Martin discusses the importance of open access data and his work in different biodiversity initiatives
2022
lab-matters
Lab Matters, Perspectives Janet Thornton, the inaugural winner of the FEBS Journal Open Science Award, explains the importance and impact of open science.
2022
lab-mattersperspectives
Science, Technology and innovation How text mining collaborations benefit our research, data resources, and the wider scientific community.
2022
sciencetechnology-and-innovation
Lab Matters Peter Harrison discusses the importance of data accessibility and his passion for biodiversity and agricultural genomics.
2022
lab-matters
Lab Matters EMBO Director Fiona Watt discusses preprints, data sharing, and evaluation in light of EMBL’s new Open Science policy
2022
lab-matters
Research highlights, Science Researchers from the MANE collaboration bring you the most comprehensive human genome annotation dataset to date.
2022
research-highlightsscience
Perspectives, Science Zamin Iqbal and his team are working with researchers all over the globe to help put a stop to Tuberculosis
2022
perspectivesscience
Announcements, Science Our researchers highlight their contributions to the Darwin Tree of Life project and how new genome annotations helps to further biodiversity research
2022
announcementsscience
Perspectives, Science The African BioGenome Project aims to safeguard biodiversity and build bioinformatics capacity across Africa
2022
perspectivesscience
Announcements, Science Open Targets, a consortium focused on drug target identification, prioritisation, and validation, announced today that Pfizer has joined as a partner.
2022
announcementsscience
Announcements, Science On track to reach an ambitious goal of 3,000 genomes sequenced by the end of 2022, what’s next for the Earth Biogenome Project?
2022
announcementsscience
Lab Matters Melissa Harrison joins EMBL-EBI as the new Team Leader of Literature Services. We found out more about her plans for open access publishing and Europe PMC.
2022
lab-matters
Lab Matters EMBL announces the release of its new Open Science Policy, contributing to positive culture change across the life sciences.
2021
lab-matters
Lab Matters Tudor Groza joins EMBL-EBI as our new Phenomics Team Lead. We found out from Tudor exactly what this new role will entail
2021
lab-matters
Lab Matters Independent study reveals that EMBL-EBI open data resources are critical for the life sciences.
2021
lab-matters
Science The BY-COVID project aims to make infectious disease data, including COVID-19, openly available to everyone.
2021
science
Lab Matters Ian Dunham walks us through his career so far including working on the human genome project, seeing his work on the cover of Nature and his current role as Director of Open Targets.
2021
lab-matters
Science MOrgAna is an open source, user-friendly, modular software that is able to analyse organoids with machine learning.
2021
science
Science 3D-Beacons Network acts as a one-stop shop for protein structures by combining and standardising data from several providers.
2021
science
Science Partners use AlphaFold, the AI system recognised last year as a solution to the protein structure prediction problem, to release more than 350,000 protein structure predictions including the entire human proteome to the scientific community.
2021
science
Science DeepMind and EMBL-EBI to make millions of protein structure predictions freely available to the scientific community.
2021
science
Science A discussion of the applications that AlphaFold DB may enable and the possible impact of the resource on science and society.
2021
science
Science Researchers establish a framework for identifying new drugs capable of exploiting a cell’s own machinery.
2021
science
Science Scientists from the CABANA project explore how open data is benefiting global research efforts.
2021
science
Lab Matters Open letter galvanises life science community in support of open COVID-19 data
2021
lab-matters
Science Bioinformaticians at EMBL-EBI and beyond are adapting computational tools to investigate coronavirus genomes and proteins.
2020
science
Lab Matters Why should researchers make artificial intelligence more transparent and how can they do it?
2020
lab-matters
Lab Matters EMBL’s Rupert Lück is engaged in developing the European Open Science Cloud (EOSC): the infrastructure that will support the future of data sharing and analysis in Europe.
2020
lab-matters
Science Open access data benefits millions of scientists around the world and is essential for a rapid response to the COVID-19 pandemic.
2020
science
Lab Matters A decadal roadmap points the way to cell-based medicine for Europe
2020
lab-matters
Lab Matters Bastian Drees is a biophysicist turned librarian, who joined EMBL in January as the new Head of Library. Here, he discusses the changing role of libraries and how they can help scientists organise and share their results.
2020
lab-matters
Lab Matters The Szilárd Library celebrates its 40th anniversary on 20 November 2019.
2019
lab-matters
Science Federated data sharing will now be possible on an unprecedented scale
2019
science
Lab Matters Ioanna Ydraiou and Bernd Pulverer spoke about their view of challenges and opportunities of OA.
2018
lab-matters
Lab Matters EMBL’s new open access policy aims to make EMBL research widely and freely accessible.
2015
lab-matters
Lab Matters Euro-BioImaging, the pan-European open access research infrastructure for biological and medical imaging technologies, invites leading European imaging facilities to submit proposals to participate. Applications to become a Euro-BioImaging node will be reviewed by a board of independent…
2013
lab-matters
Science From microscopy to computer tomography (CT) scans, imaging plays an important role in biological and biomedical research, but obtaining high-quality images often requires advanced technology and expertise, and can be costly. Euro-BioImaging, a project which launches its preparatory phase today,…
2010
science
Lab Matters The Wellcome Trust has awarded £4.7 million (€5.8 million) to EMBL’s European Bioinformatics Institute (EMBL-EBI) to support the transfer of a large collection of information on the properties and activities of drugs and a large set of drug-like small molecules from the publicly listed…
2008
lab-matters
Lab Matters Scientists will be able to access a vast collection of biomedical research at the touch of a button thanks to a major new initiative that aims to promote the free transfer of ideas in a bid to speed up scientific discovery. Based on a model currently used in the United States, UK PubMed Central…
2006
lab-matters
Lab Matters EMBOSS, the European Molecular Biology Open Software Suite, has received a vital funding boost from the UK Biotechnology and Biological Sciences Research Council (BBSRC) that will guarantee its continued maintenance under an open source license for the next three years. This ends two years of…
2006
lab-matters
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive